268 related articles for article (PubMed ID: 22052227)
1. Incidence and risk factors for chest wall toxicity after risk-adapted stereotactic radiotherapy for early-stage lung cancer.
Bongers EM; Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2052-7. PubMed ID: 22052227
[TBL] [Abstract][Full Text] [Related]
2. Clinical prognostic factors and grading system for rib fracture following stereotactic body radiation therapy (SBRT) in patients with peripheral lung tumors.
Kim SS; Song SY; Kwak J; Ahn SD; Kim JH; Lee JS; Kim WS; Kim SW; Choi EK
Lung Cancer; 2013 Feb; 79(2):161-6. PubMed ID: 23182662
[TBL] [Abstract][Full Text] [Related]
3. Chest wall volume receiving >30 Gy predicts risk of severe pain and/or rib fracture after lung stereotactic body radiotherapy.
Dunlap NE; Cai J; Biedermann GB; Yang W; Benedict SH; Sheng K; Schefter TE; Kavanagh BD; Larner JM
Int J Radiat Oncol Biol Phys; 2010 Mar; 76(3):796-801. PubMed ID: 19427740
[TBL] [Abstract][Full Text] [Related]
4. Predictors of chest wall toxicity after stereotactic ablative radiotherapy using real-time tumor tracking for lung tumors.
Park Y; Kim HJ; Chang AR
Radiat Oncol; 2017 Apr; 12(1):66. PubMed ID: 28381302
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of stereotactic ablative radiotherapy for centrally located early-stage lung cancer.
Haasbeek CJ; Lagerwaard FJ; Slotman BJ; Senan S
J Thorac Oncol; 2011 Dec; 6(12):2036-43. PubMed ID: 21892102
[TBL] [Abstract][Full Text] [Related]
6. Radiation-induced rib fracture after stereotactic body radiotherapy with a total dose of 54-56 Gy given in 9-7 fractions for patients with peripheral lung tumor: impact of maximum dose and fraction size.
Aoki M; Sato M; Hirose K; Akimoto H; Kawaguchi H; Hatayama Y; Ono S; Takai Y
Radiat Oncol; 2015 Apr; 10():99. PubMed ID: 25897487
[TBL] [Abstract][Full Text] [Related]
7. Lung stereotactic ablative radiotherapy (SABR): dosimetric considerations for chest wall toxicity.
Murray L; Karakaya E; Hinsley S; Naisbitt M; Lilley J; Snee M; Clarke K; Musunuru HB; Ramasamy S; Turner R; Franks K
Br J Radiol; 2016; 89(1058):20150628. PubMed ID: 26760508
[TBL] [Abstract][Full Text] [Related]
8. Predictors of Chest Wall Toxicity after Lung Stereotactic Ablative Radiotherapy.
Thibault I; Chiang A; Erler D; Yeung L; Poon I; Kim A; Keller B; Lochray F; Jain S; Soliman H; Cheung P
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):28-35. PubMed ID: 26129745
[TBL] [Abstract][Full Text] [Related]
9. Stereotactic body radiotherapy for central lung tumors.
Rowe BP; Boffa DJ; Wilson LD; Kim AW; Detterbeck FC; Decker RH
J Thorac Oncol; 2012 Sep; 7(9):1394-9. PubMed ID: 22843088
[TBL] [Abstract][Full Text] [Related]
10. Prediction of chest wall toxicity from lung stereotactic body radiotherapy (SBRT).
Stephans KL; Djemil T; Tendulkar RD; Robinson CG; Reddy CA; Videtic GM
Int J Radiat Oncol Biol Phys; 2012 Feb; 82(2):974-80. PubMed ID: 21300453
[TBL] [Abstract][Full Text] [Related]
11. Predicting chest wall pain from lung stereotactic body radiotherapy for different fractionation schemes.
Woody NM; Videtic GM; Stephans KL; Djemil T; Kim Y; Xia P
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):427-34. PubMed ID: 22197087
[TBL] [Abstract][Full Text] [Related]
12. Quantitative evaluation of correlation of dose and FDG-PET uptake value with clinical chest wall complications in patients with lung cancer treated with stereotactic body radiation therapy.
Algan O; Confer M; Algan S; Matthiesen C; Herman T; Ahmad S; Ali I
J Xray Sci Technol; 2015; 23(6):727-36. PubMed ID: 26756408
[TBL] [Abstract][Full Text] [Related]
13. Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer: A Retrospective, Single-Center Study of 55 Patients.
Bhandari RP; Stanford JD; Packianathan S; Duggar WN; Kanakamedala MR; Zhang X; Giri SP; Kumar PP; Harrell LM; Mangana SH; Yang C; Vijayakumar S
Oncology; 2016; 91(4):194-204. PubMed ID: 27427761
[TBL] [Abstract][Full Text] [Related]
14. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy: risk factors and dose-volume relationship.
Asai K; Shioyama Y; Nakamura K; Sasaki T; Ohga S; Nonoshita T; Yoshitake T; Ohnishi K; Terashima K; Matsumoto K; Hirata H; Honda H
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):768-73. PubMed ID: 22445398
[TBL] [Abstract][Full Text] [Related]
15. Chest wall and rib irradiation and toxicities of early-stage lung cancer patients treated with CyberKnife stereotactic body radiotherapy.
Podder T; Biswas T; Yao M; Zhang Y; Kim E; Ellis RJ; Lo SS; Machtay M
Future Oncol; 2014 Dec; 10(15):2311-7. PubMed ID: 25525841
[TBL] [Abstract][Full Text] [Related]
16. Chest wall pain and rib fracture after stereotactic radiotherapy for peripheral non-small cell lung cancer.
Voroney JP; Hope A; Dahele MR; Purdie TG; Franks KN; Pearson S; Cho JB; Sun A; Payne DG; Bissonnette JP; Bezjak A; Brade AM
J Thorac Oncol; 2009 Aug; 4(8):1035-7. PubMed ID: 19633478
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of stereotactic ablative radiotherapy in patients with potentially operable stage I non-small cell lung cancer.
Lagerwaard FJ; Verstegen NE; Haasbeek CJ; Slotman BJ; Paul MA; Smit EF; Senan S
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):348-53. PubMed ID: 22104360
[TBL] [Abstract][Full Text] [Related]
18. Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.
Coroller TP; Mak RH; Lewis JH; Baldini EH; Chen AB; Colson YL; Hacker FL; Hermann G; Kozono D; Mannarino E; Molodowitch C; Wee JO; Sher DJ; Killoran JH
PLoS One; 2014; 9(4):e94859. PubMed ID: 24728448
[TBL] [Abstract][Full Text] [Related]
19. Radiation-induced rib fractures after hypofractionated stereotactic body radiation therapy of non-small cell lung cancer: a dose- and volume-response analysis.
Pettersson N; Nyman J; Johansson KA
Radiother Oncol; 2009 Jun; 91(3):360-8. PubMed ID: 19410314
[TBL] [Abstract][Full Text] [Related]
20. Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indications.
Li Q; Swanick CW; Allen PK; Gomez DR; Welsh JW; Liao Z; Balter PA; Chang JY
Radiother Oncol; 2014 Aug; 112(2):256-61. PubMed ID: 25108807
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
